Assessment of <i>ADRB1</i> polymorphism in patients with acute coronary syndrome treated with ticagrelor and aspirin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of ADRB1 polymorphism in patients with acute coronary syndrome treated with ticagrelor and aspirin

Published:2024-04-29 Issue:3 Volume:21 Page:167-174
ISSN:1741-0541
Container-title:Personalized Medicine
language:en
Short-container-title:Personalized Medicine

Author:

Zhang Xiang¹,Yuan Qi²,Zhang Dawei³^ORCID

Affiliation:

1. Department of Cardiology, People's Hospital of Rizhao, Rizhao, 276827, China

2. Cadre Health Care Center, Inner Mongolia People’s Hospital, Hohhot, 010017, China.

3. Department of Emergency, The Affiliated Hospital of Qingdao University (Pingdu), Qingdao, 266700, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/pme-2024-0004

Reference27 articles.

1. A review on coronary artery disease, its risk factors, and therapeutics

2. Predicting protective gene biomarker of acute coronary syndrome by the circRNA-associated competitive endogenous RNA regulatory network

3. Genetic Polymorphism of CYP2C19 and Inhibitory Effects of Ticagrelor and Clopidogrel Towards Post-Percutaneous Coronary Intervention (PCI) Platelet Aggregation in Patients with Acute Coronary Syndromes

4. Morphological and Physiological Characteristics of Ruptured Plaques in Native Arteries and Neoatherosclerotic Segments: An OCT-Based and Computational Fluid Dynamics Study

5. Arterial and venous thromboembolism risk associated with blood eosinophils: A systematic review and meta‐analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP